News
News
PublISHED ON
UpDATED ON
Sweden participates in clinical WHO study
Sweden is participating in a major clinical study conducted by WHO, aimed at testing a number of antiviral medicines on patients around the world who are being treated for COVID-19.
Because more than 100 countries are taking part in the WHO study Solidarity Trial, the patient base is large. This makes it quicker to see whether any of the preparations are effective, and can begin to be used to treat the disease.
The Swedish Government recently appointed Soo Aleman, Consultant Physician at the Karolinska University Hospital and Associate Professor at Karolinska Institutet, to be the national coordinator for the Swedish part of the study. The Swedish Research Council will fund Swedish participation, as soon as the investment is formalized in the regulatory letter.
“It is important for Sweden to be part of the international study. Patients in Sweden who have suffered severe COVID-19 can now get access to potentially effective medicines. In the long term we will obtain greater knowledge of what is effective, which will also benefit patients who are not part of the study,” says Jan-Ingvar Jönsson, Secretary General of the Scientific Council for Medicine and Health and Clinical Therapy Research at the Swedish Research Council.
About the studie Solidarity trial on WHO´s website
External link.
RELATERAT INNEHÅLL
MORE WITHIN THE SAME SUBJECT AREA
-
Activity |
Published 10 April 2024
On 12 of April, there will be an inauguration of one of the new centres of excellence with funding from the Swedish Research Council: Chemical Mechanisms of Life – an interdisciplinary centre for research into the chemistry of life. Mattias Marklund,...
Keywords:
-
Article |
Published 4 April 2024
The Swedish Research Council is funding 15 centres of excellence as from 2024. The centres, which are being built up, shall carry out ground-breaking research and educational activities around a central theme.
-
News |
Published 23 February 2024
As from 2022, all clinical studies funded by the Swedish Research Council shall be registered in a public database. A recent follow-up shows that the majority of the clinical studies awarded funding in 2022 have been registered.